Related Experiment Video
Updated: May 12, 2026

11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Transcript expression in endometrial cancers from Black and White patients.
G Larry Maxwell1, Jay Allard, Chandramouli V R Gadisetti
1Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Falls Church VA 22042, USA. george.maxwell@inova.org
Gynecologic Oncology
|April 23, 2013
Summary
Gene expression in endometrial cancer did not significantly differ between Black and White patients. Further transcriptome analysis is needed to understand racial disparities in outcomes and prevalence.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Racial disparities in endometrial cancer survival exist, potentially linked to molecular differences.
- Previous research suggests molecular variations may underlie poorer outcomes in Black patients.
Purpose of the Study:
- To investigate gene expression differences in endometrial cancers between Black and White patients.
- To determine if race is associated with distinct molecular profiles in endometrial tumors.
Main Methods:
- Matched tumor specimens from 50 Black and White patients were analyzed using microarray.
- RNA was isolated from macrodissected and laser microdissected (LMD) samples.
- Gene expression data were analyzed using principal component and binary class comparison analyses.
Main Results:
- No global gene expression profiles unique to either racial group were identified.
- Subset analysis using LMD and macrodissection also failed to reveal race-specific gene expression patterns.
- Sample preparation, histology, and stage were associated with gene expression, not race.
Conclusions:
- Microarray analysis revealed no significant global or individual gene expression differences between endometrial cancers from Black and White patients.
- The study did not find molecular evidence from gene expression to explain racial disparities in endometrial cancer.
- Advanced transcriptome analysis methods are recommended to explore potential RNA-based differences contributing to outcome disparities.